Correction: The phospholipid transporter PITPNC1 links KRAS to MYC to prevent autophagy in lung and pancreatic cancer

Affiliations

• ¹ Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain.
• ² Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain.
• ³ Imaging Unit and Cancer Imaging Laboratory, University of Navarra, CIMA, Pamplona, Spain.
• ⁴ Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Centre, University of Torino, Turin, Italy.
• ⁵ University of Bordeaux, INSERM, BRIC, Bordeaux, 1312, F‑33000, France.
• ⁶ Molecular Therapies Program, University of Navarra, CIMA, Pamplona, Spain.
• ⁷ Wellcome - MRC Cambridge Stem Cell Institute (CSCI), Cambridge, UK.
• ⁸ Department of Biomedicine, University of Bergen, Bergen, Norway.
• ⁹ Bioinformatics Platform, University of Navarra, CIMA, Pamplona, Spain.
• ¹⁰ IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
• ¹¹ Department of Pathology, Anatomy and Physiology, University of Navarra, Pamplona, Spain.
• ¹² Program in Solid Tumours, University of Navarra, Centre of Applied Medical Research (CIMA), 55 Pio XII Avenue, Pamplona, 31008, Spain. silvevicent@unav.es.
• ¹³ Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain. silvevicent@unav.es.
• ¹⁴ IdiSNA, Navarra Institute for Health Research, Pamplona, Spain. silvevicent@unav.es.
• ¹⁵ Department of Pathology, Anatomy and Physiology, University of Navarra, Pamplona, Spain. silvevicent@unav.es.